These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 866730)

  • 1. [Course: Lipoprotein metabolism--physiological and clinical aspects. Role of cholesterol and triglyceride determination in the prevention of metabolic diseases and the control of preventive measures].
    Rywik S
    Przegl Lek; 1977; 34(3):369-70. PubMed ID: 866730
    [No Abstract]   [Full Text] [Related]  

  • 2. High blood cholesterol.
    National Heart, Lung and Blood Institute
    Nutr Clin Care; 2003; 6(3):108-14. PubMed ID: 14979453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid and lipoprotein profile in physiological pregnancy.
    Lippi G; Albiero A; Montagnana M; Salvagno GL; Scevarolli S; Franchi M; Guidi GC
    Clin Lab; 2007; 53(3-4):173-7. PubMed ID: 17447654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of nutrition in the development of circulatory system diseases].
    Szponar L; Respondek W
    Wiad Lek; 1994 Oct; 47(19-20):771-8. PubMed ID: 7483627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2].
    Wolffenbuttel BH; Huijberts MS
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):761-5. PubMed ID: 11346911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The importance and possibilities of developing physical endurance in health training for the prevention of cardiovascular and metabolic diseases].
    Bringmann W
    Z Arztl Fortbild (Jena); 1982 Mar; 76(6):231-4. PubMed ID: 7113266
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.
    Hokanson JE; Austin MA
    J Cardiovasc Risk; 1996 Apr; 3(2):213-9. PubMed ID: 8836866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?
    McLaughlin T; Reaven G; Abbasi F; Lamendola C; Saad M; Waters D; Simon J; Krauss RM
    Am J Cardiol; 2005 Aug; 96(3):399-404. PubMed ID: 16054467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenofibrate decreases plasma fibrinogen, improves lipid profile, and reduces uricemia.
    de la Serna G; Cadarso C
    Clin Pharmacol Ther; 1999 Aug; 66(2):166-72. PubMed ID: 10460070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials.
    Nordmann AJ; Nordmann A; Briel M; Keller U; Yancy WS; Brehm BJ; Bucher HC
    Arch Intern Med; 2006 Feb; 166(3):285-93. PubMed ID: 16476868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
    El ayachi M; Mziwira M; Vincent S; Defoort C; Portugal H; Lairon D; Belahsen R
    Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidemia therapy update: the importance of full lipid profile assessment.
    Menown IB; Murtagh G; Maher V; Cooney MT; Graham IM; Tomkin G
    Adv Ther; 2009 Jul; 26(7):711-8. PubMed ID: 19649582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma triglyceride as a risk factor for cardiovascular disease.
    Austin MA
    Can J Cardiol; 1998 May; 14 Suppl B():14B-17B. PubMed ID: 9627537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.
    Jeyarajah EJ; Cromwell WC; Otvos JD
    Clin Lab Med; 2006 Dec; 26(4):847-70. PubMed ID: 17110242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of cardiovascular disease risk in 40-65-year-old men performing recommended levels of physical activity, compared with sedentary men.
    Perkins GM; Owen A; Kearney EM; Swaine IL
    Br J Sports Med; 2009 Feb; 43(2):136-41. PubMed ID: 18308887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of cholesterol concentrations of major serum lipoprotein classes in haemodialysis patients by anion-exchange chromatography.
    Hirowatari Y; Yoshida H; Fueki Y; Ito M; Ogura Y; Sakurai N; Miida T
    Ann Clin Biochem; 2008 Nov; 45(Pt 6):571-4. PubMed ID: 18782818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma lipoprotein levels in relation to dietary habits].
    Seu A; Carbini L; D'Antonio C; Pellegrini R; Rocchitta A
    Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1945-50. PubMed ID: 7193038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dyslipidemia in diabetes mellitus].
    Niemeijer-Kanters SD; Banga JD; Erkelens DW
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):769-74. PubMed ID: 11346913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.